27 related articles for article (PubMed ID: 8883525)
1. Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
Małyszko J; Kozlowski L; Kozłowska K; Małyszko M; Małyszko J
Oncotarget; 2017 Sep; 8(39):66601-66619. PubMed ID: 29029541
[TBL] [Abstract][Full Text] [Related]
2. Iodixanol Has a Favourable Fibrinolytic Profile Compared to Iohexol in Cardiac Patients Undergoing Elective Angiography: A Double-Blind, Randomized, Parallel Group Study.
Treweeke AT; Maskrey BH; Hickson K; Miller JH; Leslie SJ; Megson IL
PLoS One; 2016; 11(1):e0147196. PubMed ID: 26784323
[TBL] [Abstract][Full Text] [Related]
3. Incidence of contrast-induced nephropathy in hospitalised patients with cancer.
Cicin I; Erdogan B; Gulsen E; Uzunoglu S; Sut N; Turkmen E; Kodaz H; Ustundag S
Eur Radiol; 2014 Jan; 24(1):184-90. PubMed ID: 24220752
[TBL] [Abstract][Full Text] [Related]
4. Similar inhibition of platelet adhesion, P-selectin expression and plasma coagulation by ioversol, iodixanol and ioxaglate.
Fägerstam JP; Ostberg AK; Eriksson AC; Fransson SG; Whiss PA
Br J Radiol; 2010 May; 83(989):401-10. PubMed ID: 19546176
[TBL] [Abstract][Full Text] [Related]
5. Comparative tolerability of contrast media used for coronary interventions.
Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
[TBL] [Abstract][Full Text] [Related]
6. Nonionic contrast agents and coagulation.
Dawson P
Invest Radiol; 1988 Nov; 23 Suppl 2():S310-7. PubMed ID: 3058638
[TBL] [Abstract][Full Text] [Related]
7. Platelet degranulation induced by some contrast media is independent of their nonionic vs ionic nature.
Grabowski EF; Jang IK; Gold H; Palacios IF; Boor SE; Rodino LJ; Michelson AD
Acta Radiol Suppl; 1995; 399():182-4. PubMed ID: 8610512
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer).
D'Anglemont De Tassigny A; IDéE JM; Corot AC
Invest Radiol; 2001 May; 36(5):276-82. PubMed ID: 11323515
[TBL] [Abstract][Full Text] [Related]
9. Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
Sakariassen KS; Buchmann M; Hamers MJ; Stormorken H
Acta Radiol; 1998 Jul; 39(4):355-61. PubMed ID: 9685818
[TBL] [Abstract][Full Text] [Related]
10. Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood.
Sakariassen KS; Barstad RM; Hamers MJ; Stormorken H
Acta Radiol; 1998 Jul; 39(4):349-54. PubMed ID: 9685817
[TBL] [Abstract][Full Text] [Related]
11. An analysis of platelet activation and aggregation produced by three classes of contrast media.
Hay KL; Bull BS
J Vasc Interv Radiol; 1995; 6(2):211-7. PubMed ID: 7540441
[TBL] [Abstract][Full Text] [Related]
12. Variability of platelet degranulation by different contrast media.
Grabowski EF; Jang IK; Gold H; Head C; Benoit SE; Michelson AD
Acad Radiol; 1996 Sep; 3 Suppl 3():S485-7. PubMed ID: 8883525
[TBL] [Abstract][Full Text] [Related]
13. Nonionic contrast media. Procoagulants or clotting innocents?
Grabowski EF; Head C; Michelson AD
Invest Radiol; 1993 Nov; 28 Suppl 5():S21-4. PubMed ID: 8282498
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
